Ligand Pharmaceuticals

Ligand Pharmaceuticals

Yahoo Finance • 19 hours ago

Agenus shares surge as company secures up to $340M to advance colon cancer trial

Agenus shares surge as company secures up to $340M to advance colon cancer trial Proactive uses images sourced from Shutterstock Agenus (Agenus Inc (NASDAQ:AGEN)) shares jumped about 100% on Monday after the biotechnology company announce... Full story

Yahoo Finance • 23 hours ago

Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)

Stock chart with green arrow moving up ©Adobe Stock Images Private Placement Strengthens Funding Position Agenus Inc. (NASDAQ:AGEN) shares climbed 13% in premarket trading on Monday after the biotechnology company announced an $85 millio... Full story

Yahoo Finance • 7 days ago

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?

Key Points CRISPR Therapeutics AG has successfully launched Casgevy, the first FDA-approved CRISPR-based gene therapy. Viking Therapeutics is a development-stage company in the high-growth obesity drug market with a promising clinical pip... Full story

Yahoo Finance • 8 days ago

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key Points CRISPR Therapeutics has transitioned to the commercial stage with the first approved CRISPR-based gene therapy. Viking Therapeutics maintains a high-potential pipeline focused on the rapidly expanding obesity and metabolic diso... Full story

Yahoo Finance • 21 days ago

Ligand Prices Upsized $625 Million Convertible Senior Notes Offering

(RTTNews) - Ligand Pharmaceuticals Incorporated (LGND) announced the pricing of an upsized $625 million offering of 0.0% convertible senior notes due 2031 in a private placement to qualified institutional buyers, strengthening the company'... Full story

Yahoo Finance • 21 days ago

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common... Full story

Yahoo Finance • 22 days ago

Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.19%.  September E-mini S&P futures (ESU26) fell -0.34%, and... Full story

Yahoo Finance • 22 days ago

Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.40%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%.  September E-mini S&P futures (ESU26) are down -0.38%, and September E... Full story

Yahoo Finance • 22 days ago

Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX) (SPY) today is up +0.21%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.50%.  September E-mini S&P futures (ESU26) are up +0.20%, and September E-mini... Full story

Yahoo Finance • 22 days ago

Ligand prices proposed $550M convertible senior notes offering

* Ligand Pharmaceuticals (LGND [https://seekingalpha.com/symbol/LGND]) said [https://seekingalpha.com/pr/20558475-ligand-announces-proposed-offering-of-550-million-of-convertible-senior-notes-due-2031] on Monday it plans to offer $550M o... Full story

Yahoo Finance • 25 days ago

Ligand Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $184.28, changing hands for $184.49/share. When a stock reaches the target an analyst has set, the anal... Full story

Yahoo Finance • last month

Stock Market Today: Nasdaq, Dow Knocked Down As Techs Sell Off; Cracker Barrel Surges (Live Coverage)

Stock Market Today: The Dow Jones index sinks 500 points Wednesday on Trump's comments. The CPI inflation rate hits 4.2% annually. Continue Reading... Full story

Yahoo Finance • last month

Ligand Announces 2026 Investor Day in New York City

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at 10:30 a.m. Eastern time at the Harvard... Full story

Yahoo Finance • last month

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Key Points 5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share. This sale represented 10.78% of Andrew Reardon's direct Common Stock holdings, reduci... Full story

Yahoo Finance • last month

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?

On May 15, 2026, Rice Hall James & Associates reported selling 102,885 shares of Establishment Labs(NASDAQ:ESTA), an estimated $7.03 million transaction based on quarterly average pricing. What happened According to the SEC filing dated... Full story

Yahoo Finance • 2 months ago

Ligand to Participate in June Investor Conferences

Ligand Pharmaceuticals JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: St... Full story

Yahoo Finance • 2 months ago

Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?

What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Rice Hall James & Associates, LLC increased its holding in Genpact(NYSE:G) by 445,743 shares during the first quarter. The estimated transac... Full story

Yahoo Finance • 2 months ago

Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?

What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Ranger Investment Management, L.P. increased its holding in WaterBridge Infrastructure LLC(NYSE:WBI) by 345,554 shares during the first quart... Full story

Yahoo Finance • 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acke... Full story

Yahoo Finance • 2 months ago

Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million

What happened According to a recent SEC filing dated April 30, 2026, Villere St Denis J & Co LLC reduced its exposure to Tidewater(NYSE:TDW) by 134,355 shares. The estimated transaction value, calculated using the quarter’s average closin... Full story